^^^
NYU Langone Medical School is conducting a random trial with a $9.5 million grant from the Bill & Melinda Gates Foundation.
In terms of the NYU clinical trial regarding prevention, researchers are enrolling 2,000 adult volunteers at six sites.
They are recruiting people who lack any COVID-19 symptoms but have been in close contact with others who have a confirmed or pending diagnosis.
On a random basis, the trial participants will receive either hydroxychloroquine or a placebo pill — vitamin C — every day for two weeks.
Each day during the 14-day period and then again on Day 28, the participants will swab their nasal passages and send the samples to researchers to detect potential COVID-19 infection.
“If everything goes as planned, the eight-week trial could provide answers by summer on whether a preventive dose of the drug is safe and effective,’’ NYU Langone said in a release.
“If so, the strategy could give health officials a much-needed boost in slowing person-to-person transmission.”
But Wait!!!
Didn't I just read that VITAMIN C is NOT PLACEBO??
I can hear it now: "no more effective than placebo"
Fuckery afoot?